INDEGENE
Back to Cashflow Statement
|
INDEGENE Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹442 Cr | ₹508 Cr | ₹130 Cr | ₹297 Cr | ₹172 Cr |
What is the latest Cash Flow from Operating Activities ratio of INDEGENE ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹442 Cr |
| Mar2024 | ₹508 Cr |
| Mar2023 | ₹130 Cr |
| Mar2022 | ₹297 Cr |
| Mar2021 | ₹172 Cr |
How is Cash Flow from Operating Activities of INDEGENE Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹442 Cr | -12.96 | |
| Mar2024 | ₹508 Cr | 289.94 | |
| Mar2023 | ₹130 Cr | -56.17 | |
| Mar2022 | ₹297 Cr | 72.67 | |
| Mar2021 | ₹172 Cr | - | |
Compare Cash Flow from Operating Activities of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹11,520.0 Cr | -2.9% | 2% | -16% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,217.0 Cr | 0.9% | 6.2% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,047.0 Cr | 1.8% | 4.8% | 6.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,872.0 Cr | 1.3% | 9.8% | 37.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,454.0 Cr | 1.7% | 5.8% | 6.7% | Stock Analytics | |
| CIPLA | ₹107,136.0 Cr | -1.3% | 0.9% | -8.9% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | -2.9% |
2% |
-16% |
| SENSEX | -1.5% |
0.8% |
8.2% |
You may also like the below Video Courses